Nautilus Biotechnology, Inc.

NASDAQ:NAUT

2.49 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q4
Operating Activities:
Net Income -16.446-18.01-18.73-17.024-15.878-15.808-14.965-13.409-14.063-14.689-15.763-16.689-14.504-10.713-8.409-5.352-3.978-3.355-2.9340.3850.6170.8570.719626.6
Depreciation & Amortization 1.6121.5971.5911.591.4831.4611.1710.9210.860.8290.8060.8690.7340.6120.6270.5980.5850.5580.60500000
Deferred Income Tax 000-1.727-0.6282.3550000000314.7520-0.5110.290000000
Stock Based Compensation 3.1843.2793.1143.0733.1063.0982.862.8332.872.5672.112.532.2481.821.3360.250.0590.0410.01900000
Change In Working Capital -0.74-1.621-1.49-0.920.179-1.557-0.921-0.1720.961-2.0630.4862.641-2.632-0.1090.078-0.339-0.136-0.483-0.322-0.355-0.178-0.088-0.1541.673
Accounts Receivables 000000000000000000000000
Change In Inventory 000000000000000000000000
Change In Accounts Payables 0.273-0.4020.0940.3710.221-0.2520.0530.289-0.207-0.249-0.3940.3740.1620.0010.7240.0660.16400.0870.1050-0.0090.01-11.3
Other Working Capital -1.013-1.219-1.584-1.291-0.042-1.305-0.053-0.4611.168-1.8140.882.267-2.794-0.11-0.646-0.405-0.3-0.483-0.322-0.461-0.178-0.08-0.16412.973
Other Non Cash Items -0.7236.1735.451-0.619-0-3.098-0.669-0.55-0.4-0.1730.0260.13-0.023-314.6540.1150.627-0.191-0.0380.011-0.119-0.492-0.829-0.688-866.571
Operating Cash Flow -13.113-15.457-16.266-13.9-11.738-13.549-12.524-10.377-9.565-13.529-12.335-10.519-14.177-8.292-6.253-4.727-3.371-3.277-2.621-0.089-0.052-0.06-0.122-238.298
Investing Activities:
Investments In Property Plant And Equipment -0.709-0.512-0.647-0.413-0.874-0.463-0.692-0.229-0.963-0.651-0.481-0.986-0.27-0.531-0.482-0.304-0.262-0.24-0.11500000
Acquisitions Net 0000.041-0.0140.002-14.249-163.1750-0.036-38.57500000149.50000000
Purchases Of Investments -43.704-15.6940-60.997-5.051-19.792-27.052-84.926-47.48-31.273-22.912-38.05-83.71-100.03500-20.0260000000
Sales Maturities Of Investments 36.9130.52320.35191814.24921.136.56738.57545.1016242940000000
Other Investing Activites 90.4114.8060.023-0.0410.014-0.00214.249163.175-10.980.03638.5757.05-83.71-84.0352429-149.5-45.3338.0011.1980001.198
Investing Cash Flow -7.50314.29422.353-41.0613.075-2.255-13.495-64.055-11.94335.07615.1826.064-83.98-84.56623.51828.696-16.288-45.5737.8861.1980001.198
Financing Activities:
Debt Repayment 000000000000000000000000
Common Stock Issued -0.5640.3190.2450.2530.0160.0980.0010.13500.1850.1560.0630.011-8.0360000000000
Common Stock Repurchased 0.289000.2640000.232000000000000.0890.0520.06-1.076-1.198
Dividends Paid 000000000000000000000000
Other Financing Activities 0.140.31900.2530.0160.0980.0010.1350.0860.1850.1560.0630.011329.442-2.0690.010.02875.8610-0.089-0.052-0.061.076145,187.802
Financing Cash Flow 0.140.3190.2450.2530.0160.0980.0010.1350.0860.1850.1560.0630.011329.442-2.0690.010.02875.86100000145,186.604
Other Information:
Effect Of Forex Changes On Cash 000-17.452-1.35218.8040000000-948.6170-24.0430000000-144,948.306
Net Change In Cash -20.476-0.8446.332-54.7071.353-15.706-26.018-74.297-21.42221.7323.003-4.392-98.146236.58415.19623.979-19.63127.011-868.4661.109-0.052-0.06-0.1221.198
Cash At End Of Period 5.41124.88525.72920.39975.10673.75389.459115.477189.774211.196189.464186.461190.853288.99952.41537.21913.2432.8715.860.8740.9631.0161.0761.198